Innovent Biologics (HK:1801) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Innovent Biologics has announced the grant of share options and restricted shares to certain employees under its 2024 Share Scheme. A total of 170,600 share options were granted to six grantees, and 683,400 restricted shares were granted to 16 grantees, all of whom are non-senior staff. These grants are subject to performance targets and have a clawback mechanism in case of misconduct or termination for cause.
For further insights into HK:1801 stock, check out TipRanks’ Stock Analysis page.
